Invesaro

Stocks Health care SERA

NASDAQ · Health care

Sera Prognostics, Inc. (SERA)

Sera Prognostics, Inc. brought in $70K of revenue over the twelve months to June 30, 2026, down 35.2% from a year earlier. It posted a net loss of $33.2M. In fiscal 2025 capital spending exceeded operating cash flow by $26.3M. At June 30, 2026 it held $4.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Revenue (last 12 months)
$70K
-35.2% year on year
Net margin
-47,475.7%

What Sera Prognostics, Inc. does

Sera Prognostics, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker SERA.

Revenue and profit by year

Revenue
FY21: $25K $25K FY21FY21: $82K $82K FY21FY22: $268K $268K FY22FY23: $306K $306K FY23FY24: $77K $77K FY24FY25: $81K $81K FY25
Net income
FY21: -$19.8M -$19.8M FY21FY21: -$35M -$35M FY21FY22: -$44.2M -$44.2M FY22FY23: -$36.2M -$36.2M FY23FY24: -$32.9M -$32.9M FY24FY25: -$31.9M -$31.9M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$81K-$36.5M-$31.9M-$0.67-$26.3M
2024$77K-$36.6M-$32.9M-$0.99-$14.2M
2023$306K-$39.8M-$36.2M-$1.16-$27.3M
2022$268K-$45.7M-$44.2M-$1.43-$35.4M
2021$82K-$35.4M-$35M-$2.33-$32.9M
2021$25K-$18M-$19.8M-$12.76-$17M

Latest SEC filings

What Sera Prognostics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 19, 2026
  2. August 12, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. August 12, 2026
  4. July 15, 2026
  5. June 30, 2026
  6. June 4, 2026
  7. June 1, 2026
  8. June 1, 2026
  9. May 6, 2026
    Quarterly report 10-Q · period to March 31, 2026
  10. May 6, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 11, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about SERA

What does Sera Prognostics, Inc. do?

Sera Prognostics, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker SERA.

Is Sera Prognostics, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $33.2M on revenue of $70K.

How much revenue does Sera Prognostics, Inc. make?

Over the twelve months to June 30, 2026 Sera Prognostics, Inc. reported revenue of $70K. That is 35.2% less than a year earlier.

When did Sera Prognostics, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 11, 2026.

Similar companies

Follow SERA

Get an email when Sera Prognostics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SERA: get an email when it files

Where the numbers come from

Financial figures are the values Sera Prognostics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.